Can a Popular Antidepressant Cause Teenage Suicide? Boston Globe Wed, 6 Aug 2003 For years, drug manufacturers and regulators (in the UK and US) have falsely maintained that antidepressants–such as Paxil (Seroxat), Prozac, and the other SSRIs–reduce the risk of suicide, and, they maintained, the drugs are not addictive. An…
FDA: regulatory protections for children. Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP August 6, 2001 To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville,…
Infomail 2004 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 31: FDA to review “missing” drug company documents Dec 30: Family of Woman Killed by AIDS Drug Test Sues Doctors, Manufacturer Dec 30: Doctors, Too, Ask: Is This Drug Right? Dec 29: Bill would shield…
Medication switched for research purposes – patient nearly dies Tue, 11 Nov 2003 The Boston Globe reports that an investigation by a state oversight agency, “uncovered numerous ethical violations at the Solomon Carter Fuller Mental Health Center by Boston Medical Center physicians contracted to treat patients there.” Boston University Medical…
Success in academic psychiatry is not measured in the improvement of patients' mental health, but rather in quantifiable commercial tender.How many grants one brings to the university, how many publications one churns out each year, and how many corporate and professional advisory boards one serves on–and how much money one…
A Boston Globe report (below) focuses on three recent reports in the Journal of the American Medical Association (JAMA) by Harvard researchers who violated the journal’s disclosure policy by failing to disclose their financial ties to companies that had the most to gain from their purported findings.
The Times’ humorous profile of JAMA’s editor attempts to trivialize the threat to public health when journals fail to maintain the integrity of science-based medicine.
It is difficult to believe this latest announcement laying claim to a new "under treated" psychiatric disorder–Intermittent Explosive Disorder (IED) is not a parody !!
A ray of hope that might help cleanse medicine of its corrupt interaction with drug company marketers.
Our criticism of a high risk, speculative drug experiment conducted on healthy children and adolescents at Yale University’s Psychiatric Institute was validated by a federal investigation: and our criticism is now validated by the principle investigator, Dr. Thomas McGlashan.
The Boston Globe reports (below): “More than 50 years after psychiatrists began widely dispensing drugs to treat mental illness, the profession is coming face to face with a humbling reality: Its treatments often fail, leaving millions of patients [ ] to suffer while doctors search for something that works.”
"Lobbyists influence how the government spends your money, but financially conflicted physicians can threaten your well-being."
